Previous 10 | Next 10 |
2024-06-25 10:29:34 ET More on S&P 500 Index: Odds For A Soft Landing Improve S&P 6300? Is That Outside The Realm Of Possibility? Nervous Calm Hangs Over The Markets Nasdaq, S&P, Dow are mixed after selloff in tech stocks Is the Nvidia-led...
2024-05-26 09:55:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...
2024-05-22 14:42:59 ET More on Hologic Hologic: Women's Health Play Looks Healthier Itself Hologic, Inc. (HOLX) Q2 2024 Earnings Call Transcript Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M Hologic Q2 2024 Earnings Preview ...
2024-05-13 03:56:51 ET Summary Hologic's women's health business benefited from the pandemic but is now facing headwinds that will end in 2024. The company has a strong balance sheet, solid track record, and reasonable valuation, making it an attractive investment. Hologic rec...
2024-05-02 23:24:08 ET Call Start: 16:30 Call End: 17:24 Hologic, Inc. (HOLX) Q2 2024 Earnings Conference Call May 2, 2024 16:30 ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President & Chief Executiv...
2024-05-02 16:05:05 ET Read the full article on Seeking Alpha For further details see: Hologic Non-GAAP EPS of $1.03 beats by $0.05, revenue of $1.02B beats by $20M
– Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comp...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
2024-05-01 17:20:29 ET More on Hologic Hologic: Prospects For Growth As Headwinds Disappear Hologic, Inc. (HOLX) Q1 2024 Results - Earnings Call Transcript Hologic digital cytology system wins FDA approval Hologic Non-GAAP EPS of $0.98 beats by $0.03, revenue...
2024-04-29 16:17:17 ET More on Hologic Hologic: Prospects For Growth As Headwinds Disappear Hologic digital cytology system wins FDA approval Hologic Non-GAAP EPS of $0.98 beats by $0.03, revenue of $1.01B beats by $26.42M Seeking Alpha’s Quant Rating ...
News, Short Squeeze, Breakout and More Instantly...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Endomagnetics Ltd (Endomag), a privately held UK-based developer of breast cancer surgery technologies, for approximately $310 million. This press release features mul...
New Survey Reveals Women Struggle to Prioritize Their Health Millions of women in the United States have missed screenings for serious, often life-threatening conditions, according to a new survey released today by women’s health innovator Hologic, Inc. (Nasdaq: HOLX). This p...